Výsledky vyhledávání - Umesh Chaudhari

  • Zobrazuji výsledky 1 - 14 z 14
Upřesnit hledání
  1. 1
    MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes

    MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes Autor Umesh Chaudhari, Harshal Nemade, John Antonydas Gaspar, Jürgen Hescheler, Jan G. Hengstler, Agapios Sachinidis

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes

    Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes Autor Umesh Chaudhari, James K. Ellis, Vilas Wagh, Harshal Nemade, Jürgen Hescheler, Hector C. Keun, Agapios Sachinidis

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

    Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODY... Autor Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

    Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO... Autor Christopher P. Cannon, Bertrand Cariou, Dirk Blom, James M. McKenney, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab

    Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab Autor Jennifer G. Robinson, Robert S. Rosenson, Michel Farnier, Umesh Chaudhari, William J. Sasiela, Laurence Merlet, Kathryn Miller, John J.P. Kastelein

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study

    PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Autor Stephen R. Daniels, Sonia Caprio, Umesh Chaudhari, Garen Manvelian, Marie T. Baccara-Dinet, Aurélie Brunet, Michel Scemama, Virginie Loizeau, Éric Bruckert

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials

    Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated... Autor Helen M. Colhoun, Jennifer G. Robinson, Michel Farnier, Bertrand Cariou, Dirk Blom, Dean J. Kereiakes, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

    Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer Autor Giancarlo Agnelli, Daniel J. George, Ajay K. Kakkar, Winfield S. Fisher, Michael R. Lassen, Patrick Mismetti, Patrick Mouret, Umesh Chaudhari, Francesca Lawson, Alexander G.G. Turpie

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Human Skin-Derived Stem Cells as a Novel Cell Source for In Vitro Hepatotoxicity Screening of Pharmaceuticals

    Human Skin-Derived Stem Cells as a Novel Cell Source for In Vitro Hepatotoxicity Screening of Pharmaceuticals Autor Robim M. Rodrigues, Joery De Kock, Steven Branson, Mathieu Vinken, Kesavan Meganathan, Umesh Chaudhari, Agapios Sachinidis, Olivier Govaere, Tania Roskams, Veerle De Boe, Tamara Vanhaecke, Vera Rogiers

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment

    Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety asses... Autor Umesh Chaudhari, Harshal Nemade, Vilas Wagh, John Antonydas Gaspar, James K. Ellis, Sureshkumar Perumal Srinivasan, Dimitry Spitkovski, Filomain Nguemo, Jochem Louisse, Susanne Bremer, Jürgen Hescheler, Hector C. Keun, Jan G. Hengstler, Agapios Sachinidis

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

    Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events Autor Jennifer G. Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S.G. Stroes, Gisle Langslet, Frederick J. Raal, Mahfouz El Shahawy, Michael J. Koren, Norman E. Lepor, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, John J.P. Kastelein

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells

    Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells Autor Patrício Godoy, Wolfgang Schmidt‐Heck, Karthick Natarajan, Baltasar Lucendo‐Villarin, Dagmara Szkolnicka, Annika Asplund, Petter Björquist, Agata Widera, Regina Stöber, Gisela Campos, Seddik Hammad, Agapios Sachinidis, Umesh Chaudhari, Georg Damm, Thomas S. Weiß, Andreas K. Nüssler, Jane Synnergren, Karolina Edlund, Barbara Küppers-Munther, David C. Hay, Jan G. Hengstler

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue

    Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue Autor Patrício Godoy, Agata Widera, Wolfgang Schmidt‐Heck, Gisela Campos, Christoph Meyer, Cristina Cadenas, Raymond Reif, Regina Stöber, Seddik Hammad, Larissa Pütter, Kathrin Gianmoena, Rosemarie Marchan, Ahmed Ghallab, Karolina Edlund, Andreas K. Nüssler, Wolfgang E. Thasler, Georg Damm, Daniel Seehofer, Thomas S. Weiß, Olaf Dirsch, Uta Dahmen, Rolf Gebhardt, Umesh Chaudhari, Kesavan Meganathan, Agapios Sachinidis, Jens M. Kelm, Ute Hofmann, René P. Zahedi, Reinhard Guthke, Nils Blüthgen, Steven Dooley, Jan G. Hengstler

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

    Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease:... Autor Ahmet Özen, Voranush Chongsrisawat, Asena Pınar Sefer, Burcu Kolukısa, Jessica J. Jalbert, Karoline A. Meagher, Taylor Brackin, Hagit Baris Feldman, Safa Barış, Elif Karakoç-Aydıner, Rabia Ergelen, Ivan J. Fuss, Heather Moorman, Narissara Suratannon, Kanya Suphapeetiporn, Lorah Perlee, Olivier Harari, George D. Yancopoulos, Michael J. Lenardo, Jutta Miller, Orly Eshach Adiv, Sevgi Bilgiç Eltan, Melek Yorgun Altunbaş, Mary Magliocco, Helen Matthews, Beatriz E. Marciano, Pantipa Chatchatee, Caryn F. Trbovic, Michael E. Burczynski, Umesh Chaudhari, Yusuf Usta, Cansu Altuntaş, Sibel Yavuz, Abdulkadir Baştürk, Fatma Demirbaş, Erdem Topal, Ayhan Gazi Kalaycı, Wanlapa Weerapakorn, A MARTINEZ, Adriana Bottero

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: